Vice President, Cardiovascular
Responsibilities
Jim Helm is Vice President of Cardiovascular leading the US Cardiovascular business at AstraZeneca. As a member of the US Leadership Team, Jim also shares accountability for the delivery of the overall US business goals and priorities.
Prior Experience
Jim has over 27 years of industry experience, including marketing, sales and operations in support of emerging to mature brands in a variety of therapeutic areas. Jim has experience in launching brands, extending product life cycles, and generating value from under-resourced brands by increasing contribution with strategic initiatives.
Jim joined AstraZeneca in 2004 as Vice President, AZENITY and has successfully led the team in managing AstraZeneca’s late-stage portfolio, which represents over a quarter of US sales. Prior to coming to AstraZeneca, Jim was Vice President, Pharma New Business for Wyeth, where as a Therapeutic Chairperson, he provided global leadership for emerging brands, including licensing opportunities.
Jim began his career as a sales representative, and has served in numerous sales and marketing roles. Along with his experience in cardiovascular, metabolism, and neuroscience therapeutic areas, Jim also has significant experience in the area of Managed Markets.
Education
- Bachelor’s degree in physiology/pre-med, University of Texas
- Master of business administration, Amber University
